Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition

Atsushi Umemura; Eek Joong Park; Koji Taniguchi; Jun Hee Lee; Shabnam Shalapour; Mark A. Valasek; Mariam Aghajan; Hayato Nakagawa; Ekihiro Seki; Michael N. Hall; Michael Karin

doi:10.1016/j.cmet.2014.05.001

Related publications

Article2013

Inflammation and liver tumorigenesis

Beicheng Sun, Michael Karin

Article2002

Persistent Inhibition of Neointimal Hyperplasia After Sirolimus-Eluting Stent Implantation

Muzaffer Değertekin, Patrick W. Serruys, David P. Foley, Kengo Tanabe, Evelyn Regar, Jeroen Vos, Peter Smits, Wim J. van der Giessen, Marcel van den Brand, Pim de Feyter, Jeffrey J. Popma

Circulation

Article2010

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

Eek Joong Park, Jun Hee Lee, Guann‐Yi Yu, Guobin He, Syed R. Ali, Ryan G. Holzer, Christoph H. Österreicher, Hiroyuki Takahashi, Michael Karin

Article2016

The Effect of Mtorc1 Inhibition on Nafld and Subsequent Hcc Development

Atsushi Umemura, Yoshio Itoh, Michael Karin

Article2018

Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling

Debanjan Dhar, Laura Antonucci, Hayato Nakagawa, Ju Youn Kim, Elisabeth Glitzner, Stefano Caruso, Shabnam Shalapour, Ling Yang, Mark A. Valasek, Sooyeon Lee, Kerstin Minnich, Ekihiro Seki, Jan Tuckermann, Maria Sibilia, Jessica Zucman‐Rossi, Michael Karin